These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21602347)

  • 21. Role of oxidative stress in persister tolerance.
    Wu Y; Vulić M; Keren I; Lewis K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AldB controls persister formation in Escherichia coli depending on environmental stress.
    Kawai Y; Matsumoto S; Ling Y; Okuda S; Tsuneda S
    Microbiol Immunol; 2018 May; 62(5):299-309. PubMed ID: 29577369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins.
    Leszczynska D; Matuszewska E; Kuczynska-Wisnik D; Furmanek-Blaszk B; Laskowska E
    PLoS One; 2013; 8(1):e54737. PubMed ID: 23358116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
    Karki P; Mohiuddin SG; Kavousi P; Orman MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
    Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
    mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Evolution of Escherichia coli Persister Levels Using Cyclic Antibiotic Treatments.
    Van den Bergh B; Michiels JE; Michiels J
    Methods Mol Biol; 2016; 1333():131-43. PubMed ID: 26468106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GlpD and PlsB participate in persister cell formation in Escherichia coli.
    Spoering AL; Vulic M; Lewis K
    J Bacteriol; 2006 Jul; 188(14):5136-44. PubMed ID: 16816185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putrescine controls the formation of Escherichia coli persister cells tolerant to aminoglycoside netilmicin.
    Tkachenko AG; Kashevarova NM; Karavaeva EA; Shumkov MS
    FEMS Microbiol Lett; 2014 Dec; 361(1):25-33. PubMed ID: 25283595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trans-translation mediates tolerance to multiple antibiotics and stresses in Escherichia coli.
    Li J; Ji L; Shi W; Xie J; Zhang Y
    J Antimicrob Chemother; 2013 Nov; 68(11):2477-81. PubMed ID: 23812681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
    Völzing KG; Brynildsen MP
    mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes.
    Knudsen GM; Ng Y; Gram L
    Appl Environ Microbiol; 2013 Dec; 79(23):7390-7. PubMed ID: 24056460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth.
    Cho J; Carr AN; Whitworth L; Johnson B; Wilson KS
    Microbiology (Reading); 2017 Mar; 163(3):308-321. PubMed ID: 28113053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
    Lechner S; Lewis K; Bertram R
    J Mol Microbiol Biotechnol; 2012; 22(4):235-44. PubMed ID: 22986269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polynucleotide Phosphorylase Mediates a New Mechanism of Persister Formation in Escherichia coli.
    Wu N; Zhang Y; Zhang S; Yuan Y; Liu S; Xu T; Cui P; Zhang W; Zhang Y
    Microbiol Spectr; 2023 Feb; 11(1):e0154622. PubMed ID: 36475972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation.
    Korch SB; Hill TM
    J Bacteriol; 2006 Jun; 188(11):3826-36. PubMed ID: 16707675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic basis of persister tolerance to aminoglycosides in Escherichia coli.
    Shan Y; Lazinski D; Rowe S; Camilli A; Lewis K
    mBio; 2015 Apr; 6(2):. PubMed ID: 25852159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic Study of the Survival and Resuscitation Mechanisms of Filamentous Persisters in an Evolved Escherichia coli Population from Cyclic Ampicillin Treatment.
    Sulaiman JE; Lam H
    mSystems; 2020 Jul; 5(4):. PubMed ID: 32723793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.